SCAFFIDI, LISA
 Distribuzione geografica
Continente #
NA - Nord America 61
EU - Europa 21
AS - Asia 10
Totale 92
Nazione #
US - Stati Uniti d'America 61
IT - Italia 9
SG - Singapore 6
FI - Finlandia 4
CN - Cina 3
FR - Francia 2
GB - Regno Unito 2
RU - Federazione Russa 2
DE - Germania 1
IN - India 1
SE - Svezia 1
Totale 92
Città #
Chandler 22
Fairfield 7
Padova 6
Medford 4
Princeton 4
Santa Clara 4
Cambridge 3
Helsinki 3
Beijing 2
San Diego 2
Singapore 2
Acton 1
Ashburn 1
Houston 1
Lappeenranta 1
London 1
Paris 1
Pune 1
Roxbury 1
Sarego 1
Stockholm 1
Totale 69
Nome #
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 35
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population 23
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome 19
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis 19
Totale 96
Categoria #
all - tutte 1.075
article - articoli 1.075
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 0 0 0 0 0 0 0 14 10
2022/202346 10 2 3 6 6 2 0 3 6 7 1 0
2023/202418 0 4 1 1 1 2 1 0 2 0 3 3
2024/20258 0 6 2 0 0 0 0 0 0 0 0 0
Totale 96